Sayonara M. Viana

Salvador, BA, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Autoantibodies in long COVID in a black/mixed population compared with recovered and pre-pandemic controls.

Autoantibodies in long COVID in a black/mixed population compared with recovered and pre-pandemic controls.

Journal: Frontiers in immunology
Published: August 13, 2025

Immunization with centrin-Deficient Leishmania braziliensis Does Not Protect against Homologous Challenge.

Immunization with centrin-Deficient Leishmania braziliensis Does Not Protect against Homologous Challenge.

Journal: Vaccines
Published: February 06, 2024

Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins.

Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins.

Journal: Emerging microbes & infections
Published: August 30, 2022

Immune Response to LinB13, a Lutzomyia Intermedia Salivary Protein Correlates With Disease Severity in Tegumentary Leishmaniasis.

Immune Response to LinB13, a Lutzomyia Intermedia Salivary Protein Correlates With Disease Severity in Tegumentary Leishmaniasis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 23, 2021

Targeted Deletion of Centrin in Leishmania braziliensis Using CRISPR-Cas9-Based Editing.

Targeted Deletion of Centrin in Leishmania braziliensis Using CRISPR-Cas9-Based Editing.

Journal: Frontiers in cellular and infection microbiology
Published: October 06, 2021

A pilot and open trial to evaluate topical Bacterial Cellulose bio-curatives in the treatment of cutaneous leishmaniasis caused by L. braziliensis.

A pilot and open trial to evaluate topical Bacterial Cellulose bio-curatives in the treatment of cutaneous leishmaniasis caused by L. braziliensis.

Journal: Acta tropica
Published: June 08, 2021

Photodynamic inactivation of Leishmania braziliensis doubly sensitized with uroporphyrin and diamino-phthalocyanine activates effector functions of macrophages in vitro.

Photodynamic inactivation of Leishmania braziliensis doubly sensitized with uroporphyrin and diamino-phthalocyanine activates effector functions of macrophages in vitro.

Journal: Scientific reports
Published: January 17, 2020

Generation and Characterization of a Dual-Reporter Transgenic Leishmania braziliensis Line Expressing eGFP and Luciferase.

Generation and Characterization of a Dual-Reporter Transgenic Leishmania braziliensis Line Expressing eGFP and Luciferase.

Journal: Frontiers in cellular and infection microbiology
Published: September 11, 2019

The Long Pentraxin 3 (PTX3) Suppresses Immunity to Cutaneous Leishmaniasis by Regulating CD4+ T Helper Cell Response.

The Long Pentraxin 3 (PTX3) Suppresses Immunity to Cutaneous Leishmaniasis by Regulating CD4+ T Helper Cell Response.

Journal: Cell reports
Published: February 22, 2019

Photodynamic Vaccination of BALB/c Mice for Prophylaxis of Cutaneous Leishmaniasis Caused by Leishmania amazonensis.

Photodynamic Vaccination of BALB/c Mice for Prophylaxis of Cutaneous Leishmaniasis Caused by Leishmania amazonensis.

Journal: Frontiers in microbiology
Published: November 16, 2017

Activity of cycloartane-type triterpenes and sterols isolated from Musa paradisiaca fruit peel against Leishmania infantum chagasi.

Activity of cycloartane-type triterpenes and sterols isolated from Musa paradisiaca fruit peel against Leishmania infantum chagasi.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 24, 2014
Showing 1-11 of 11

Last Updated: 09/26/2026